US govt sues Novartis over health care fraud

Last Updated: Wednesday, April 24, 2013, 08:55

The US government has claimed that Novartis gave kickbacks to pharmacies to switch kidney transplant patients from competitors' drugs to its own.

SC order on Novartis will impact investment in India: USIBC

Last Updated: Wednesday, April 3, 2013, 08:50

Over 40 countries including China, Russia and Taiwan have already granted a patent for Novartis' Glivec and India now stands out as unique for not granting a patent to this incremental innovation, the statement said.

After Novartis, Glenmark in diabetes drug patent violation case

Last Updated: Tuesday, April 2, 2013, 23:03

Pharma firm MSD, the India affiliate of US-based Merck & Co, on Tuesday said it has sued Mumbai-based Glenmark for infringing on its patents for two diabetes drugs Januvia and Janumet.

MNC lobby upset over Novartis patent verdict

Last Updated: Tuesday, April 2, 2013, 16:04

The SC judgment caps about seven year of tussle launched by Novartis seeking patent cover for its cancer medicine Glivec.

'Glivec patent denial to hit investment in med advancement'

Last Updated: Monday, April 1, 2013, 23:17

Indian Supreme Court's decision Monday to deny patent to Swiss firm Novartis for its cancer drug Glivec will negatively impact the ability of companies to invest in medical and technological advancements, the US Chamber of Commerce said.

Supreme Court decision on Novartis "historic": Sharma

Last Updated: Monday, April 1, 2013, 20:38

Commerce and Industry Minister Anand Sharma Monday described the Supreme Court judgement rejecting Novartis AG plea for its cancer drug as "historic" and said Indian Patent Law conforms fully with global obligations under the WTO IPR pact - TRIPS.

Will not invest on R&D in India, says Novartis

Last Updated: Monday, April 1, 2013, 18:19

Swiss pharma major Novartis Monday said it will not invest on research and development in India and move R&D to favourable destinations following the Supreme Court order rejecting its patent plea on cancer drug Glivec.

SC decision on Novartis to benefit poor patients: Pharma cos

Last Updated: Monday, April 1, 2013, 15:09

Novartis, however, said: "This ruling is a setback for patients that will hinder medical progress for diseases without effective treatment options".

Supreme Court rejects Novartis cancer drug Glivec patent plea

Last Updated: Monday, April 1, 2013, 09:27

Glivec, used in treating chronic myeloid leukemia and some other cancers, costs a patient about Rs 1.2 lakh/month, much higher than Rs 8,000 which is the price of the generic drug.

Novartis shares up 4% after Swiss-promoter says to cut stake

Last Updated: Thursday, March 28, 2013, 17:49

Shares of Novartis India on Wednesday closed higher by 3.75 percent, adding Rs 68 crore to its market capitalisation, after its Swiss-promoter said it intends to reduce stake in the Indian entity.

Novartis AG to reduce promoters stake in Novartis India

Last Updated: Thursday, March 28, 2013, 13:30

Novartis India on Thursday said it's Swiss-promoter Novartis AG intends to reduce its stake in the Indian entity to enable it to meet Sebi guidelines on the minimum public shareholding in the listed companies.

Novartis India Q2 net down 8.89% at Rs 39.34 cr

Last Updated: Thursday, October 25, 2012, 19:47

Drug firm Novartis India Thursday said its net profit declined by 8.89 percent to Rs 39.34 crore for the quarter ended September 30, 2012 over the same period last fiscal.